{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T15:57:50Z","timestamp":1778774270753,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T00:00:00Z","timestamp":1549238400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100008258","name":"Hamedan University of Medical Sciences","doi-asserted-by":"publisher","award":["9507134134"],"award-info":[{"award-number":["9507134134"]}],"id":[{"id":"10.13039\/501100008258","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00784-019-02830-2","type":"journal-article","created":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T01:15:05Z","timestamp":1549242905000},"page":"3987-3993","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of the effect of teriparatide therapy on mandibular fracture healing in rats with medication-related osteonecrosis of the jaw"],"prefix":"10.1007","volume":"23","author":[{"given":"Mohammad","family":"Zandi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arash","family":"Dehghan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Payam","family":"Amini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shideh","family":"Doulati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Rezaeian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,4]]},"reference":[{"key":"2830_CR1","doi-asserted-by":"publisher","first-page":"791","DOI":"10.2165\/11585470-000000000-00000","volume":"71","author":"EM Lewiecki","year":"2011","unstructured":"Lewiecki EM (2011) Safety of long-term bisphosphonate therapy for the management of osteoporosis. Drugs 71:791\u2013814","journal-title":"Drugs"},{"key":"2830_CR2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/hed.21422","volume":"33","author":"MP Maahs","year":"2011","unstructured":"Maahs MP, Azambuja AA, Campos MM, Salum FG, Cherubini K (2011) Association between bisphosphonates and jaw osteonecrosis: a study in Wistar rats. Head Neck 33:199\u2013207","journal-title":"Head Neck"},{"key":"2830_CR3","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.joms.2008.12.030","volume":"67","author":"C Wongchuensoontorn","year":"2009","unstructured":"Wongchuensoontorn C, Liebehenschel N, Wagner K, Fakler O, Gutwald R, Schmelzeisen R, Sauerbier S (2009) Pathological fractures in patients caused by bisphosphonate-related osteonecrosis of the jaws: report of 3 cases. J Oral Maxillofac Surg 67:1311\u20131316","journal-title":"J Oral Maxillofac Surg"},{"key":"2830_CR4","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O\u2019Ryan F (2014) American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg 72:1938\u20131956","journal-title":"J Oral Maxillofac Surg"},{"key":"2830_CR5","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ijscr.2015.02.049","volume":"10","author":"A Jowett","year":"2015","unstructured":"Jowett A, Abdullakutty A, Bailey M (2015) Pathological fracture of the coronoid process secondary to medication-related osteonecrosis of the jaw (MRONJ). Int J Surg Case Rep 10:162\u2013165","journal-title":"Int J Surg Case Rep"},{"key":"2830_CR6","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.jcms.2013.11.005","volume":"42","author":"P Barba-Recreo","year":"2014","unstructured":"Barba-Recreo P, Del Castillo Pardo de Vera JL, Garc\u00eda-Arranz M, Y\u00e9benes L, Burgue\u00f1o M (2014) Zoledronic acid - related osteonecrosis of the jaws. Experimental model with dental extractions in rats. J Craniomaxillofac Surg 42:744\u2013750","journal-title":"J Craniomaxillofac Surg"},{"key":"2830_CR7","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.oooo.2013.11.490","volume":"117","author":"EH Dayisoylu","year":"2014","unstructured":"Dayisoylu EH, \u00dcng\u00f6r C, Tosun E, Ers\u00f6z S, Kadioglu Duman M, Taskesen F, Senel F\u00c7 (2014) Does an alkaline environment prevent the development of bisphosphonate-related osteonecrosis of the jaw? An experimental study in rats. Oral Surg Oral Med Oral Pathol Oral Radiol 117:329\u2013334","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"2830_CR8","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jhsa.2008.12.011","volume":"34","author":"TD Rozental","year":"2009","unstructured":"Rozental TD, Vazquez MA, Chacko AT, Ayogu N, Bouxsein ML (2009) Comparison of radiographic fracture healing in the distal radius for patients on and off bisphosphonate therapy. J Hand Surg Am 34:595\u2013602","journal-title":"J Hand Surg Am"},{"key":"2830_CR9","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2106\/JBJS.K.01181","volume":"95","author":"BJ Edwards","year":"2013","unstructured":"Edwards BJ, Bunta AD, Lane J, Odvina C, Rao DS, Raisch DW, McKoy JM, Omar I, Belknap SM, Garg V, Hahr AJ, Samaras AT, Fisher MJ, West DP, Langman CB, Stern PH (2013) Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project. J Bone Joint Surg Am 95:297\u2013307","journal-title":"J Bone Joint Surg Am"},{"key":"2830_CR10","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.bone.2013.06.003","volume":"56","author":"JA Meganck","year":"2013","unstructured":"Meganck JA, Begun DL, McElderry JD, Swick A, Kozloff KM, Goldstein SA, Morris MD, Marini JC, Caird MS (2013) Fracture healing with alendronate treatment in the Brtl\/+ mouse model of osteogenesis imperfecta. Bone 56:204\u2013212","journal-title":"Bone"},{"key":"2830_CR11","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1359\/JBMR.040814","volume":"19","author":"CF Munns","year":"2004","unstructured":"Munns CF, Rauch F, Zeitlin L, Fassier F, Glorieux FH (2004) Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate. J Bone Miner Res 19:1779\u20131786","journal-title":"J Bone Miner Res"},{"key":"2830_CR12","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1359\/jbmr.2001.16.3.429","volume":"16","author":"C Li","year":"2001","unstructured":"Li C, Mori S, Li J, Kaji Y, Akiyama T, Kawanishi J, Norimatsu H (2001) Long-term effect of incadronate disodium (YM-175) on fracture healing of femoral shaft in growing rats. J Bone Miner Res 16:429\u2013436","journal-title":"J Bone Miner Res"},{"key":"2830_CR13","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.jocn.2011.04.048","volume":"19","author":"PH Tu","year":"2012","unstructured":"Tu PH, Liu ZH, Lee ST, Chen JF (2012) Treatment of repeated and multiple new-onset osteoporotic vertebral compression fractures with teriparatide. J Clin Neurosci 19:532\u2013535","journal-title":"J Clin Neurosci"},{"key":"2830_CR14","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s00198-013-2570-8","volume":"25","author":"S Kuroshima","year":"2014","unstructured":"Kuroshima S, Entezami P, McCauley LK, Yamashita J (2014) Early effects of parathyroid hormone on bisphosphonate\/steroid-associated compromised osseous wound healing. Osteoporos Int 25:1141\u20131150","journal-title":"Osteoporos Int"},{"key":"2830_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ijscr.2016.02.028","volume":"21","author":"M Yao","year":"2016","unstructured":"Yao M, Shimo T, Ono Y, Obata K, Yoshioka N, Sasaki A (2016) Successful treatment of osteonecrosis-induced fractured mandible with teriparatide therapy: a case report. Int J Surg Case Rep 21:151\u2013153","journal-title":"Int J Surg Case Rep"},{"key":"2830_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11914-010-0006-3","volume":"8","author":"SV Bukata","year":"2010","unstructured":"Bukata SV, Puzas JE (2010) Orthopedic uses of teriparatide. Curr Osteoporos Rep 8:28\u201333","journal-title":"Curr Osteoporos Rep"},{"key":"2830_CR17","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1016\/j.injury.2018.07.006","volume":"49","author":"M Zandi","year":"2018","unstructured":"Zandi M, Shokri A, Mousavi M, Rajaei S, Mohammad Gholi Mezerji N (2018) Does zoledronate therapy make mandibular bone susceptible to fracture? A radiographical and biomechanical study in rats. Injury 49:1746\u20131749. \nhttps:\/\/doi.org\/10.1016\/j.injury.2018.07.006","journal-title":"Injury"},{"key":"2830_CR18","first-page":"261","volume":"44","author":"M Zandi","year":"2016","unstructured":"Zandi M, Dehghan A, Malekzadeh H, Janbaz P, Ghadermazi K, Amini P (2016) Introducing a protocol to create bisphosphonate-related osteonecrosis of the jaw in rat animal model. J Craniomaxillofac Surg 44:261\u2013268","journal-title":"J Craniomaxillofac Surg"},{"key":"2830_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/01.blo.0000087322.60612.14","volume":"414","author":"AC Perry","year":"2003","unstructured":"Perry AC, Prpa B, Rouse MS, Piper KE, Hanssen AD, Steckelberg JM, Patel R (2003) Levofloxacin and trovafloxacin inhibition of experimental fracture-healing. Clin Orthop Relat Res 414:95\u2013100","journal-title":"Clin Orthop Relat Res"},{"key":"2830_CR20","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.joms.2005.12.051","volume":"65","author":"MM Curi","year":"2007","unstructured":"Curi MM, Cossolin GSI, Koga DH, Ara\u00fajo SR, Feher O, dos Santos MO, Zardetto C (2007) Treatment of avascular osteonecrosis of the mandible in cancer patients with a history of bisphosphonate therapy by combining bone resection and autologous platelet-rich plasma: report of 3 cases. J Oral Maxillofac Surg 65:349\u2013355","journal-title":"J Oral Maxillofac Surg"},{"key":"2830_CR21","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.bjoms.2007.03.016","volume":"45","author":"P Vescovi","year":"2007","unstructured":"Vescovi P, Merigo E, Meleti M, Fornaini C, Nammour S, Manfredi M (2007) Nd:YAG laser biostimulation of bisphosphonate-associated necrosis of the jawbone with and without surgical treatment. Br J Oral Maxillofac Surg 45:628\u2013632","journal-title":"Br J Oral Maxillofac Surg"},{"key":"2830_CR22","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.bjoms.2010.08.005","volume":"49","author":"NM McLeod","year":"2011","unstructured":"McLeod NM, Patel V, Kusanale A, Rogers SN, Brennan PA (2011) Bisphosphonate osteonecrosis of the jaw: a literature review of UK policies versus international policies on the management of bisphosphonate osteonecrosis of the jaw. Br J Oral Maxillofac Surg 49:335\u2013342","journal-title":"Br J Oral Maxillofac Surg"},{"key":"2830_CR23","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1563\/1548-1336(2007)33[371:UOPPIT]2.0.CO;2","volume":"33","author":"CY Lee","year":"2007","unstructured":"Lee CY, David T, Nishime M (2007) Use of platelet-rich plasma in the management of oral biphosphonate-associated osteonecrosis of the jaw: a report of 2 cases. J Oral Implantol 33:371\u2013382","journal-title":"J Oral Implantol"},{"issue":"Suppl 1","key":"2830_CR24","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1016\/S0020-1383(16)30009-2","volume":"47","author":"C Collinge","year":"2016","unstructured":"Collinge C, Favela J (2016) Use of teriparatide in osteoporotic fracture patients. Injury 47(Suppl 1):S36\u2013S38","journal-title":"Injury"},{"key":"2830_CR25","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.bone.2005.02.002","volume":"36","author":"S Komatsubara","year":"2005","unstructured":"Komatsubara S, Mori S, Mashiba T, Nonaka K, Seki A, Akiyama T, Miyamoto K, Cao Y, Manabe T, Norimatsu H (2005) Human parathyroid hormone (1\u201334) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora. Bone 36:678\u2013687","journal-title":"Bone"},{"key":"2830_CR26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00223-011-9503-3","volume":"89","author":"B Mognetti","year":"2011","unstructured":"Mognetti B, Marino S, Barberis A, Martin AS, Bala Y, Di Carlo F, Boivin G, Barbos MP (2011) Experimental stimulation of bone healing with teriparatide: histomorphometric and microhardness analysis in a mouse model of closed fracture. Calcif Tissue Int 89:163\u2013171","journal-title":"Calcif Tissue Int"},{"issue":"Suppl 1","key":"2830_CR27","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1016\/S0020-1383(13)70013-5","volume":"44","author":"L Pietrogrande","year":"2013","unstructured":"Pietrogrande L, Raimondo E (2013) Teriparatide in the treatment of non-unions: scientific and clinical evidences. Injury 44(Suppl 1):S54\u2013S57","journal-title":"Injury"},{"key":"2830_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.bonr.2015.04.003","volume":"3","author":"Y Kim","year":"2015","unstructured":"Kim Y, Tanaka C, Tada H, Kanoe H, Shirai T (2015) Radiographic features of teriparatide-induced healing of femoral fractures. Bone Rep 3:11\u201314","journal-title":"Bone Rep"},{"key":"2830_CR29","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s00198-014-2622-8","volume":"25","author":"KM Kim","year":"2014","unstructured":"Kim KM, Park W, Oh SY, Kim HJ, Nam W, Lim SK (2014) Distinctive role of 6-month teriparatide treatment on intractable bisphosphonate-related osteonecrosis of the jaw. Osteoporos Int 25:1625\u20131632","journal-title":"Osteoporos Int"},{"key":"2830_CR30","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1007\/s00198-011-1882-9","volume":"23","author":"YD Kwon","year":"2012","unstructured":"Kwon YD, Lee DW, Choi BJ, Lee JW, Kim DY (2012) Short-term TRPD therapy as an adjunctive modality for bisphosphonate related osteonecrosis of the jaws. Osteoporos Int 23:2721\u20132725","journal-title":"Osteoporos Int"},{"key":"2830_CR31","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.ijom.2015.07.018","volume":"44","author":"H Kakehashi","year":"2015","unstructured":"Kakehashi H, Ando T, Minamizato T, Nakatani Y, Kawasaki T, Ikeda H (2015) Administration of teriparatide improves the symptoms of advanced bisphosphonate-related osteonecrosis of the jaw: preliminary findings. Int J Oral Maxillofac Surg 44:1558\u20131564","journal-title":"Int J Oral Maxillofac Surg"},{"key":"2830_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1196\/annals.1402.089","volume":"1117","author":"RG Russell","year":"2007","unstructured":"Russell RG, Xia Z, Dunford JE, Oppermann U, Kwaasi A, Hulley PA, Kavanagh KL, Triffitt JT, Lundy MW, Phipps RJ, Barnett BL, Coxon FP, Rogers MJ, Watts NB, Ebetino FH (2007) Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy. Ann N Y Acad Sci 1117:209\u2013257","journal-title":"Ann N Y Acad Sci"},{"key":"2830_CR33","first-page":"873","volume":"28","author":"A Corrado","year":"2010","unstructured":"Corrado A, Neve A, Maruotti N, Gaudio A, Marucci A, Cantatore FP (2010) Dose-dependent metabolic effect of zoledronate on primary human osteoblastic cell cultures. Clin Exp Rheumatol 28:873\u2013879","journal-title":"Clin Exp Rheumatol"},{"key":"2830_CR34","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1359\/jbmr.2002.17.11.2038","volume":"17","author":"A Nakajima","year":"2002","unstructured":"Nakajima A, Shimoji N, Shiomi K, Shimizu S, Moriya H, Einhorn TA, Yamazaki M (2002) Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34). J Bone Miner Res 17:2038\u20132047","journal-title":"J Bone Miner Res"},{"key":"2830_CR35","unstructured":"Eli Lilly and Co. (2002) United States Package Insert: Forteo [teriparatide (rDNA origin) injection]. Indianapolis, IN"},{"key":"2830_CR36","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","volume":"22","author":"S Khosla","year":"2007","unstructured":"Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D, Gagel RF, Gilsanz V, Guise T, Koka S, McCauley LK, McGowan J, McKee MD, Mohla S, Pendrys DG, Raisz LG, Ruggiero SL, Shafer DM, Shum L, Silverman SL, Van Poznak CH, Watts N, Woo SB, Shane E, American Society for Bone and Mineral Research (2007) Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 22:1479\u20131491","journal-title":"J Bone Miner Res"},{"key":"2830_CR37","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.ijom.2017.01.023","volume":"46","author":"S Caldroney","year":"2017","unstructured":"Caldroney S, Ghazali N, Dyalram D, Lubek JE (2017) Surgical resection and vascularized bone reconstruction in advanced stage medication-related osteonecrosis of the jaw. Int J Oral Maxillofac Surg 46:871\u2013876","journal-title":"Int J Oral Maxillofac Surg"},{"key":"2830_CR38","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.joms.2008.01.026","volume":"66","author":"R Landesberg","year":"2008","unstructured":"Landesberg R, Cozin M, Cremers S, Woo V, Kousteni S, Sinha S, Garrett-Sinha L, Raghavan S (2008) Inhibition of oral mucosal cell wound healing by bisphosphonates. J Oral Maxillofac Surg 66:839\u2013847","journal-title":"J Oral Maxillofac Surg"},{"key":"2830_CR39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jcms.2016.10.015","volume":"45","author":"M Zandi","year":"2017","unstructured":"Zandi M, Dehghan A, Janbaz P, Malekzadeh H, Amini P (2017) The starting point for bisphosphonate-related osteonecrosis of the jaw: alveolar bone or oral mucosa? A randomized, controlled experimental study. J Craniomaxillofac Surg 45:157\u2013161","journal-title":"J Craniomaxillofac Surg"},{"key":"2830_CR40","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1080\/01926230252929882","volume":"30","author":"JL Vahle","year":"2002","unstructured":"Vahle JL, Sato M, Long GG, Young JK, Francis PC, Engelhardt JA (2002) Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety. Toxicol Pathol 30:312\u2013321","journal-title":"Toxicol Pathol"},{"key":"2830_CR41","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1002\/jbmr.1768","volume":"27","author":"EB Andrews","year":"2012","unstructured":"Andrews EB, Gilsenan AW, Midkiff K, Sherrill B, Wu Y, Mann BH, Masica D (2012) The US postmarketing surveillance study of adult osteosarcoma and teriparatide: study design and findings from the first 7 years. J Bone Miner Res 27:2429\u20132437","journal-title":"J Bone Miner Res"},{"key":"2830_CR42","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1359\/JBMR.051023","volume":"21","author":"AH Tashjian Jr","year":"2006","unstructured":"Tashjian AH Jr, Gagel RF (2006) Teriparatide [human PTH(1-34)]: 2.5 years of experience on the use and safety of the drug for the treatment of osteoporosis. J Bone Miner Res 21:354\u2013365","journal-title":"J Bone Miner Res"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00784-019-02830-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-019-02830-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-019-02830-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T19:08:55Z","timestamp":1583262535000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00784-019-02830-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,4]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["2830"],"URL":"https:\/\/doi.org\/10.1007\/s00784-019-02830-2","relation":{},"ISSN":["1432-6981","1436-3771"],"issn-type":[{"value":"1432-6981","type":"print"},{"value":"1436-3771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,4]]},"assertion":[{"value":"11 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study, formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}